Amphastar Pharmaceuticals, Inc. (AMPH) income statement
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3010% below fair value
$29.71+0.61 (+2.10%)
Close on Nov 18, 2026Market cap $1.26BP/E 17.5Yield –
Amphastar Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?